2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Manage- ment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:3036 7. 14. Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Inter- ventional Procedures. Available at: https://www.ncbi.nlm.nih.gov/books/ NBK554353/. Accessed October 12, 2020. 15. Thornhill MH, Gibson TB, Cutler E, et al. Antibiotic prophylaxis and inci- dence of endocarditis before and after the 2007 AHA recommendations. J Am Coll Cardiol. 2018;72:2443 54. 16. Desimone DC, Tleyjeh IM, Correa de Sa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after pub- lication of the 2007 American Heart Association s endocarditis prevention guidelines. Circulation. 2012;126:60 4. 17. Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocardi- tis in England, 2000 13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219 28. 18. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocardi- tis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968 76. 19. Pasquali SK, He X, Mohamad Z, et al. Trends in endocarditis hospitaliza- tions at US children s hospitals: impact of the 2007 American Heart As- sociation antibiotic prophylaxis guidelines. Am Heart J. 2012;163:894 9. 20. Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis in- cidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070 6. 21. Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline rec- ommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392. 22. Strom BL, Abrutyn E, Berlin JA, et al. 